Viridian Therapeutics, Inc. (VRDN) revenue

Revenue · fiscal 2025
$70.85M

Viridian Therapeutics, Inc. (VRDN) reported revenue of $70.85M in fiscal 2025 (the year ended December 31, 2025). That is 23359.9% higher than the $302.00K of fiscal 2024. Figures as of 18 Nov 2026, 04:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$70.85M
Change on fiscal 2024
+23359.9%
Growth, 5 years
+132.2% a year
Growth, 10 years
+28.6% a year
Highest on record
$70.85Mfiscal 2025
Lowest on record
$302.00Kfiscal 2024
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Viridian Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 132.2% a year; over ten years the rate was 28.6% a year. Across the 13 fiscal years on record (2013–2025), the highest was $70.85M in fiscal 2025 and the lowest $302.00K in fiscal 2024.

History · 13 fiscal years

Revenue by fiscal year

Viridian Therapeutics, Inc. revenue, year by year

Viridian Therapeutics, Inc. (VRDN) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$70.85M 23,359.9% up
2024$302.00K 3.8% down
2023$314.00K 82.3% down
2022$1.77M 40.2% down
2021$2.96M 182.2% up
2020$1.05M 76.5% down
2019$4.46M 46.8% down
2018$8.39M 109.5% up
2017$4.00M 15.1% up
2016$3.48M 39.1% down
2015$5.71M 12.0% down
2014$6.48M 18.1% up
2013$5.49M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on VRDN

Viridian Therapeutics, Inc., figure by figure

Viridian Therapeutics, Inc. (VRDN) overview: price, valuation and scorecard

Viridian Therapeutics, Inc. revenue: questions and answers

What is Viridian Therapeutics, Inc.'s revenue?

Viridian Therapeutics, Inc. (VRDN) reported revenue of $70.85M in fiscal 2025 (the year ended December 31, 2025). That is 23359.9% higher than the $302.00K of fiscal 2024.

What is the growth rate of Viridian Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 132.2% a year; over ten years the rate was 28.6% a year.

What are the highest and lowest revenue figures on record for Viridian Therapeutics, Inc.?

Across the 13 fiscal years on record (2013–2025), the highest was $70.85M in fiscal 2025 and the lowest $302.00K in fiscal 2024.

How is Viridian Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Viridian Therapeutics, Inc. (VRDN) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/VRDN/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.